WATCH: Advocates Urge Congress to Increase Access to Innovative Diagnostics

Effectively treating a disease begins with an accurate diagnosis, but current Medicare reimbursement policy limits patient access to many innovative diagnostic radiopharmaceuticals that can diagnose and monitor conditions such as Parkinson’s disease, advanced cardiac disease, cancers of the prostate, breast, and brain. The technology has also been integral to validating an Alzheimer’s diagnosis for many patients, like Geri Taylor, by confirming the presence of amyloid plaques in the brain.

Watch as Geri’s husband, Jim, talks about why Congressional action is needed to improve access to these critical drugs:

Please join Jim, Geri and countless other advocates in asking Congress to pass the Facilitating Innovative Nuclear Diagnostics (FIND) Act and give clinicians all the tools necessary to diagnose Alzheimer’s disease and many others.

Click here to send you letter today.

More Articles

Advocates Across the Country Speak Out Against Medicare Cuts

October 18, 2022

These pandemic years have been challenging, especially for doctors, who have worked to adapt, treat, and lead us…

Read More

How Focused Ultrasound Helped One Patient Treat His Prostate Cancer

July 28, 2022

When Michael Swann turned 60, his urologist explained the importance of monitoring prostate-specific antigen (PSA) levels as an…

Read More

“Focused Ultrasound Gave Me My Life Back”

June 27, 2022

Focused ultrasound is a procedure that helps patients with tremors improve their quality of life. Using concentrated ultrasound…

Read More

WATCH: Patient Advocate Explains the Importance of Safety in Medical Imaging

May 9, 2022

Medical imaging saves lives. Scans allow providers to diagnose diseases earlier, improving patient outcomes, but the complexity of…

Read More